(Q44844488)

English

Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study

scientific article published in May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

8

object named as

Willem Weimar

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Teun van Gelder

6

object named as

Teun van Gelder

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Cornelis G ter Meulen

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Iza van Riemsdijk

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Ronald J Hené

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Maarten H L Christiaans

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

George F Borm

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Luuk B Hilbrands

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Andries J Hoitsma

9

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

American Journal of Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

803-810

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

Steroids withdrawal after 3 months of successful renal transplantation using a tacrolimus- and mycophenolate-based immunosuppression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

Tacrolimus and new onset diabetes mellitus: the effect of steroid weaning.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

The Banff 97 working classification of renal allograft pathology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

Two doses of daclizumab are sufficient for prolonged interleukin-2Ralpha chain blockade

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00419.X

21 January 2018

Identifiers

10.1111/J.1600-6143.2004.00419.X

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44844488&oldid=2142132077"